Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Tight regulation of transcription factors, such as PU.1, is crucial for generation of all hematopoietic lineages. We previously reported that mice with a deletion of an upstream regulatory element (URE) of the gene encoding PU.1 (Sfpi1) developed acute myeloid leukemia. Here we show that the URE has an essential role in orchestrating the dynamic PU.1 expression pattern required for lymphoid development and tumor suppression. URE deletion ablated B2 cells but stimulated growth of B1 cells in mice. The URE was a PU.1 enhancer in B cells but a repressor in T cell precursors. TCF transcription factors coordinated this repressor function and linked PU.1 to Wnt signaling. Failure of appropriate PU.1 repression in T cell progenitors with URE deletion disrupted differentiation and induced thymic transformation. Genome-wide DNA methylation assessment showed that epigenetic silencing of selective tumor suppressor genes completed PU.1-initiated transformation of lymphoid progenitors with URE deletion. These results elucidate how a single transcription factor, PU.1, through the cell context-specific activity of a key cis-regulatory element, affects the development of multiple cell lineages and can induce cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an upstream regulatory element of PU.1 functions as a PU.1 enhancer in B cells but as a repressor in T-cell precursors.30”
From PELI2 regulates early B-cell progenitor differentiation and related leukemia via the IL-7R expression (2023) · cites this paper as [30]
In the citing paper
“The best current candidates for this silencing activity include GATA-3 (104, 105), TCF-1 or LEF-1 (37), and especially Runx1 (80, 150–152), probably working in a dose-dependent combination, although the mechanism through which they finally achieve the ability to repress PU.1 has not yet been reported.”
From Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development (2019) · cites this paper as [37]
In the citing paper
“PU.1 is crucial for lymphomyeloid development, and its stage-specific expression is critical in preventing leukemic transformation.1,2”
From Macrophage development from HSCs requires PU.1-coordinated microRNA expression (2011) · cites this paper as [1]
In the citing paper
“in the erythroid lineage, in which SPI1 exerts an oncogenic function by blocking differentiation.”
From HDAC1 and PRC2 mediate combinatorial control in SPI1/PU.1-dependent gene repression in murine erythroleukaemia (2022) · cites this paper as [20]
Citations
Cites
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253 · cited 1×
“A hierarchical model has been established in which hematopoietic stem cells (HSCs) give rise to common lymphoid progenitor cells (CLPs), which are believed to manifest the earliest representatives of all lymphocyte”
BackgroundSelf-citationA role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · cited 1×
“Sfpi1 -null mice undergo early lethality and lack B-lymphocytes and mature myeloid cells in fetal liver”
BackgroundAberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
Self-citationIntestinal polyposis in mice with a dominant stable mutation of the beta -catenin gene
Harada, N. (1999) · The EMBO Journal · doi:10.1093/emboj/18.21.5931 · Cited by 1,212
High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP
Rodríguez, C. I., Buchholz, F., Galloway, J., Sequerra, R., Kasper, J., Ayala, R., Stewart, A. F., & Dymecki, S. M. (2000) · Nature Genetics · doi:10.1038/75973 · Cited by 1,159
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
Induction of T Cell Development from Hematopoietic Progenitor Cells by Delta-like-1 In Vitro
Schmitt, T. M., & Zúñiga-Pflücker, J. C. (2002) · Immunity · doi:10.1016/s1074-7613(02)00474-0 · Cited by 1,120 · cited 1×
“We established the T cell line from a UREΔ mouse by culturing primary thymic lymphoma cells on OP9-DL1 stroma layer”
Method
Cited by
Transcription factors in myeloid development: balancing differentiation with transformation
Rosenbauer, F., & Tenen, D. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2024 · Cited by 606
Self-citationGenomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
“SPI1 Lethal, myeloid, B cells (197-203) SPIB B cells (204) SPIC Red pulp macrophages (205) ETV6 Yolk sac, hematopoietic stem cells (206,207) ETV7 N/A, no mouse ortholog ELF3 Intestine (208) EHF N/A ELF5 Lethal, embryo patterning, mammary gland (209,210) ELF4 NK cells, NK-T cells (211) ELF2 N/A ELF1 No defect (212) SPD…”
Launching the T-cell-lineage developmental programme
Rothenberg, E. V., Moore, J. E., & Yui, M. A. (2008) · Nature Reviews Immunology · doi:10.1038/nri2232 · Cited by 476
“However, indirect evidence suggests that WNT signalling may already be occurring in most ETP”
BackgroundKirstetter, P., Anderson, K., Porse, B. T., Jacobsen, S. E. W., & Nerlov, C. (2006) · Nature Immunology · doi:10.1038/ni1381 · Cited by 446
“Consistent with that idea, a Tcf binding site in the Sfpi1 enhancer located −14 kilobases from the transcription start site has been shown to have repressor function in early T cells, and mice lacking that enhancer accumulate DN1–DN2 T cell”
BackgroundHematopoietic Cytokines Can Instruct Lineage Choice
Rieger, M. A., Hoppe, P. S., Smejkal, B. M., Eitelhuber, A. C., & Schroeder, T. (2009) · Science · doi:10.1126/science.1171461 · Cited by 409
An Early T Cell Lineage Commitment Checkpoint Dependent on the Transcription Factor Bcl11b
Li, L., Leid, M., & Rothenberg, E. V. (2010) · Science · doi:10.1126/science.1188989 · Cited by 397
The Transcriptional Regulation of B Cell Lineage Commitment
Nutt, S. L., & Kee, B. L. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.010 · Cited by 387
B-1 B Cell Development in the Fetus and Adult
Montecino-Rodriguez, E., & Dorshkind, K. (2012) · Immunity · doi:10.1016/j.immuni.2011.11.017 · Cited by 351
Laiosa, C. V., Stadtfeld, M., Xie, H., de Andres-Aguayo, L., & Graf, T. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.011 · Cited by 351
Developmental gene networks: a triathlon on the course to T cell identity
Yui, M. A., & Rothenberg, E. V. (2014) · Nature Reviews Immunology · doi:10.1038/nri3702 · Cited by 342
Zhang, J. A., Mortazavi, A., Williams, B. A., Wold, B. J., & Rothenberg, E. V. (2012) · Cell · doi:10.1016/j.cell.2012.01.056 · Cited by 337
“H3Ac disappeared from the promoter while H3K4me2 marks in the upstream cis-regulatory elements of the gene (Rosenbauer et al., 2006; Zarnegar et al., 2010) narrowed as transcription declined (Fig.”
The Protean Nature of Cells in the B Lymphocyte Lineage
Hardy, R. R., Kincade, P. W., & Dorshkind, K. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.013 · Cited by 269
PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
Huang, G., Zhang, P., Hirai, H., Elf, S., Yan, X., Chen, Z., Koschmieder, S., Okuno, Y., Dayaram, T., Growney, J. D., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.7 · Cited by 259
Self-citationDETERMINANTS OF LYMPHOID-MYELOID LINEAGE DIVERSIFICATION
Laiosa, C. V., Stadtfeld, M., & Graf, T. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090742 · Cited by 259
How transcription factors drive choice of the T cell fate
Hosokawa, H., & Rothenberg, E. V. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00426-6 · Cited by 247
Xu, L., Cao, Y., Xie, Z., Huang, Q., Bai, Q., Yang, X., He, R., Hao, Y., Wang, H., Zhao, T., et al. (2015) · Nature Immunology · doi:10.1038/ni.3229 · Cited by 224
“Subsequently, we performed reporter assays using a self-inactivating retroviral system 34 .”
Long-term, multilineage hematopoiesis occurs in the combined absence of β-catenin and γ-catenin
Jeannet, G., Scheller, M., Scarpellino, L., Duboux, S., Gardiol, N., Back, J., Kuttler, F., Malanchi, I., Birchmeier, W., Leutz, A., et al. (2008) · Blood · doi:10.1182/blood-2007-07-102558 · Cited by 215
Self-citationSpooner, C. J., Cheng, J. X., Pujadas, E., Laslo, P., & Singh, H. (2009) · Immunity · doi:10.1016/j.immuni.2009.07.011 · Cited by 188
“1 enhancer resulted in a decrease, rather than an increase, in bone marrow-derived B lineage progeny in vivo (Rosenbauer et al., 2006).”
BackgroundRieger, M. A., & Schroeder, T. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008250 · Cited by 187
“Subtle changes and misregulation of individual TFs will directly impact normal differentiation and can lead to leukemia (Rosenbauer et al. 2006).”
BackgroundThe role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis
Burda, P., Laslo, P., & Stopka, T. (2010) · Leukemia · doi:10.1038/leu.2010.104 · Cited by 184
Yu, S., Zhou, X., Steinke, F. C., Liu, C., Chen, S.-C., Zagorodna, O., Jing, X., Yokota, Y., Meyerholz, D. K., Mullighan, C. G., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.009 · Cited by 185
“Interestingly, upregulation of PU.1 was not observed in premalignant thymocytes or lymphomas lacking the –14 kb element, and thus a ‘‘hit-and-run’’ mechanism has been proposed for a role of PU.1 in thymocyte transformation (Rosenbauer et al., 2006).”
BackgroundMethodInfluentialSelf-citationCandidate silencer elements for the human and mouse genomes
Doni Jayavelu, N., Jajodia, A., Mishra, A., & Hawkins, R. D. (2020) · Nature Communications · doi:10.1038/s41467-020-14853-5 · Cited by 184
Essential role of Jun family transcription factors in PU.1 knockdown–induced leukemic stem cells
Steidl, U., Rosenbauer, F., Verhaak, R. G. W., Gu, X., Ebralidze, A., Otu, H. H., Klippel, S., Steidl, C., Bruns, I., Costa, D. B., et al. (2006) · Nature Genetics · doi:10.1038/ng1898 · Cited by 184
“1 or other genes that are expressed at highest levels in mature cells because of the presence of such cells in total bone marrow sample”
BackgroundSelf-citationLichtinger, M., Ingram, R., Hannah, R., Müller, D., Clarke, D., Assi, S. A., Lie-A-Ling, M., Noailles, L., Vijayabaskar, M. S., Wu, M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.275 · Cited by 180
“…blood cells from haematopoietic precursors requires additional transcription factors and includes the ETS-family member PU.1 whose balanced expression is required for correct myeloid and lymphoid development (McKercher et al , 1996; Scott et al , 1997; Rosenbauer et al , 2006; Leddin et al , 2011).”
Self-citationEbralidze, A. K., Guibal, F. C., Steidl, U., Zhang, P., Lee, S., Bartholdy, B., Jorda, M. A., Petkova, V., Rosenbauer, F., Huang, G., et al. (2008) · Genes & Development · doi:10.1101/gad.1654808 · Cited by 176
Self-citationSima, C., & Glogauer, M. (2013) · Periodontology 2000 · doi:10.1111/prd.12032 · Cited by 163
Staber, P. B., Zhang, P., Ye, M., Welner, R. S., Nombela-Arrieta, C., Bach, C., Kerenyi, M., Bartholdy, B. A., Zhang, H., Alberich-Jordà, M., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.007 · Cited by 158
“1 expression in bone marrow in comparison to wild-type (WT) mice and leads to the development of leukemias or lymphomas (Rosenbauer et al., 2006; Rosenbauer et al., 2004).”
BackgroundResultInfluentialSelf-citationFetal B-cell lymphopoiesis and the emergence of B-1-cell potential
Dorshkind, K., & Montecino-Rodriguez, E. (2007) · Nature Reviews Immunology · doi:10.1038/nri2019 · Cited by 158
“1 transcription factor, are required for the development of B-2 cells but not B-1 cell”
BackgroundEpigenetic regulation of normal and malignant hematopoiesis
Rice, K. L., Hormaeche, I., & Licht, J. D. (2007) · Oncogene · doi:10.1038/sj.onc.1210755 · Cited by 158
“NSD3 is located in a genomic region amplified in breast cancer (Angrand et al., 2001) and is also fused to NUP98 in AML associated with the t(8;11) translocation (Rosati et al., 2002). hDOT1L is an HMTase that lacks the SET domain and specifically methylates H3K79, a residue located within the globular domain of histo…”
BackgroundInfluentialMYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
Vargova, K., Curik, N., Burda, P., Basova, P., Kulvait, V., Pospisil, V., Savvulidi, F., Kokavec, J., Necas, E., Berkova, A., et al. (2011) · Blood · doi:10.1182/blood-2010-05-285064 · Cited by 144
New perspectives in B-1 B cell development and function
Montecino‐Rodriguez, E., & Dorshkind, K. A. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.07.005 · Cited by 149
Choi, J., Diao, H., Faliti, C. E., Truong, J., Rossi, M., Bélanger, S., Yu, B., Goldrath, A. W., Pipkin, M. E., & Crotty, S. (2020) · Nature Immunology · doi:10.1038/s41590-020-0706-5 · Cited by 142
Mielke, L. A., Groom, J. R., Rankin, L. C., Seillet, C., Masson, F., Putoczki, T., & Belz, G. T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301228 · Cited by 139
“1, a known target gene of Tcf7 (46), was shown to induce the ST2 promoter (47).”
BackgroundRecurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia
Seki, M., Kimura, S., Isobe, T., Yoshida, K., Ueno, H., Nakajima-Takagi, Y., Wang, C., Lin, L., Kon, A., Suzuki, H., et al. (2017) · Nature Genetics · doi:10.1038/ng.3900 · Cited by 138
The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity
Liu, Y., Cheney, M. D., Gaudet, J., Chruszcz, M., Lukasik, S. M., Sugiyama, D., Lary, J. W., Cole, J. L., Dauter, Z., Minor, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.012 · Cited by 155
“Reductions in PU.1 dosage were recently shown to cause an accumulation of c-kit+ hematopoietic precursors in bone marrow, and predisposed mice to acute myeloid leukemia and T cell lymphoma (Rosenbauer et al., 2004, 2006).”
Two distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells
Leddin, M., Perrod, C., Hoogenkamp, M., Ghani, S., Assi, S., Heinz, S., Wilson, N. K., Follows, G., Schönheit, J., Vockentanz, L., et al. (2011) · Blood · doi:10.1182/blood-2010-08-302976 · Cited by 131
“1 expression in HSCs, myeloid cells and B cells.(13) Such URE mutants develop a multi-lineage differentiation block which rapidly transits into an acute myeloid leukemia.”
BackgroundMethodInfluentialSelf-citationA Functional Screen to Identify Novel Effectors of Hematopoietic Stem Cell Activity
Deneault, É., Cellot, S., Faubert, A., Laverdure, J., Fréchette, M., Chagraoui, J., Mayotte, N., Sauvageau, M., Ting, S. B., & Sauvageau, G. (2009) · Cell · doi:10.1016/j.cell.2009.03.026 · Cited by 141
PU.1 Level-Directed Chromatin Structure Remodeling at the Irf8 Gene Drives Dendritic Cell Commitment
Schönheit, J., Kuhl, C., Gebhardt, M. L., Klett, F. F., Riemke, P., Scheller, M., Huang, G., Naumann, R., Leutz, A., Stocking, C., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.007 · Cited by 127
Self-citationMacrophages and Cardiovascular Health
Frodermann, V., & Nahrendorf, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00068.2017 · Cited by 127
B-1 B cells: development, selection, natural autoantibody and leukemia
Hardy, R. R. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.07.010 · Cited by 129
Guibal, F. C., Alberich-Jorda, M., Hirai, H., Ebralidze, A., Levantini, E., Di Ruscio, A., Zhang, P., Santana-Lemos, B. A., Neuberg, D., Wagers, A. J., et al. (2009) · Blood · doi:10.1182/blood-2008-10-182071 · Cited by 126
Self-citationMacrophage development from HSCs requires PU.1-coordinated microRNA expression
Ghani, S., Riemke, P., Schönheit, J., Lenze, D., Stumm, J., Hoogenkamp, M., Lagendijk, A., Heinz, S., Bonifer, C., Bakkers, J., et al. (2011) · Blood · doi:10.1182/blood-2011-02-335141 · Cited by 123
Self-citationC/EBPα binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment
Yeamans, C., Wang, D., Paz-Priel, I., Torbett, B. E., Tenen, D. G., & Friedman, A. D. (2007) · Blood · doi:10.1182/blood-2007-03-080291 · Cited by 118
Self-citationSteidl, U., Steidl, C., Ebralidze, A., Chapuy, B., Han, H.-J., Will, B., Rosenbauer, F., Becker, A., Wagner, K., Koschmieder, S., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30525 · Cited by 114
Self-citationPU.1: A crucial and versatile player in hematopoiesis and leukemia
Kastner, P., & Chan, S. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.01.026 · Cited by 101
Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development
Rothenberg, E. V., Hosokawa, H., & Ungerbäck, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00228 · Cited by 99
Transcription factors drive B cell development
Hagman, J., & Lukin, K. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.01.007 · Cited by 82
C/EBPα: A tumour suppressor in multiple tissues?
Schuster, M. B., & Porse, B. T. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.02.003 · Cited by 99
Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
Ji, M.-M., Huang, Y., Huang, J.-Y., Wang, Z., Fu, D., Liu, H., Liu, F., Lebœuf, C., Wang, L., Ye, J., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.182444 · Cited by 104
“1 is involved in the development of all hematopoietic lineages(32) and regulates lymphoid cell growth and transformation.(33) Aberrant PU.”
BackgroundA gene regulatory network armature for T lymphocyte specification
Georgescu, C., Longabaugh, W. J. R., Scripture-Adams, D. D., David-Fung, E.-S., Yui, M. A., Zarnegar, M. A., Bolouri, H., & Rothenberg, E. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806501105 · Cited by 95
“Also incorporated is evidence from the literature on some additional Notch inputs (28), possible linkages both upstream [TCF-1 (Tcf7), Runx (20, 21)] and downstream [Gfi1, Egr2 (2)] of PU.1, and additional data on changes in gene expression that follow commitment, during TCR-dependent selection in the DN3b and DN4 sta…”
BackgroundThe RUNX1–PU.1 axis in the control of hematopoiesis
Imperato, M. R., Cauchy, P., Obier, N., & Bonifer, C. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1762-8 · Cited by 94
Surprising new roles for PU.1 in the adaptive immune response
Carotta, S., Wu, L., & Nutt, S. L. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00955.x · Cited by 93
“1 expression initiated cellular transformation in an early T-cell progenitor (52).”
BackgroundInfluentialBcl11b and combinatorial resolution of cell fate in the T-cell gene regulatory network
Longabaugh, W. J. R., Zeng, W., Zhang, J. A., Hosokawa, H., Jansen, C. S., Li, L., Romero-Wolf, M., Liu, P., Kueh, H. Y., Mortazavi, A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610617114 · Cited by 89
T Cell Lineage Commitment: Identity and Renunciation
Rothenberg, E. V. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003703 · Cited by 89
“Two cis-regulatory regions of the Sfpi1 (PU.1) gene seem to mediate repression: a multifunctional Upstream Regulatory Element (48, 49) and a recently described, cell-type–specific silencer (50).”
BackgroundKnockdown of PU.1 AS lncRNA inhibits adipogenesis through enhancing PU.1 mRNA translation
Pang, W.-J., Lin, L., Xiong, Y., Wei, N., Wang, Y., Shen, Q. W., & Yang, G.-S. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24595 · Cited by 103
Montecino-Rodriguez, E., Fice, M., Casero, D., Berent-Maoz, B., Barber, C. L., & Dorshkind, K. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.012 · Cited by 87
“A requirement for precise regulation of PU.1 expression during hematopoietic development has been extensively discussed (Dakic et al., 2007; Rosenbauer et al., 2006; Staber et al., 2013).”
BackgroundResultInfluentialMultilayered specification of the T-cell lineage fate.
Rothenberg, E. V., Zhang, J., & Li, L. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00964.x · Cited by 81
“Therefore, the Notch signals that turn on CD25 and activate GATA-3 and TCF-1 and initiate Bcl11b induction are not in themselves sufficient to dictate the repression of the progenitor-cell genes.”
BackgroundInfluentialCytokines, Transcription Factors, and the Initiation of T-Cell Development
Hosokawa, H., & Rothenberg, E. V. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028621 · Cited by 98
“Together with Notch signaling, GATA3 and TCF1 antagonize the progenitor-specific factors in these pro-T cells and regulate specification and commitment of T cells (Rosenbauer et al. 2006; Hosoya et al. 2009; Germar et al. 2011; Weber et al. 2011; De Obaldia et al. 2013b; Garcia-Ojeda et al. 2013; Scripture-Adams et al…”
BackgroundPU.1 and Haematopoietic Cell Fate: Dosage Matters
Mak, K. S., Funnell, A. P. W., Pearson, R. C. M., & Crossley, M. (2011) · International Journal of Cell Biology · doi:10.1155/2011/808524 · Cited by 77
Programming for T-lymphocyte fates: modularity and mechanisms
Rothenberg, E. V. (2019) · Genes & Development · doi:10.1101/gad.327163.119 · Cited by 80
“However, both gain- and loss-of-function experiments clearly show that GATA3 (Taghon et al. 2007; Scripture-Adams et al. 2014) and Runx1 (Hoogenkamp et al. 2007; Huang et al. 2008; Zarnegar et al. 2010; Hosokawa et al. 2018b) participate in the repression of Spi1 around the time of commitment.”
BackgroundInfluentialChamphekar, A., Damle, S. S., Freedman, G., Carotta, S., Nutt, S. L., & Rothenberg, E. V. (2015) · Genes & Development · doi:10.1101/gad.259879.115 · Cited by 74
“Even inefficient silencing of PU.1 can cause T-cell leukemia (Rosenbauer et al. 2006).”
BackgroundIs PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?
Dakic, A., Wu, L., & Nutt, S. L. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.006 · Cited by 72
PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia
Pang, S. H. M., Minnich, M., Gangatirkar, P., Zheng, Z., Ebert, A., Song, G., Dickins, R. A., Corcoran, L. M., Mullighan, C. G., Busslinger, M., et al. (2016) · Leukemia · doi:10.1038/leu.2016.27 · Cited by 69
From inception to output, Tcf1 and Lef1 safeguard development of T cells and innate immune cells
Steinke, F. C., & Xue, H. (2014) · Immunologic Research · doi:10.1007/s12026-014-8545-9 · Cited by 73
“1 ([53] and our unpublished observations), and it is suggested that transiently enhanced PU.”
BackgroundHoogenkamp, M., Krysinska, H., Ingram, R., Huang, G., Barlow, R., Clarke, D., Ebralidze, A., Zhang, P., Tagoh, H., Cockerill, P. N., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00905-07 · Cited by 63
“This repressive activity is dependent on a binding site for the transcription factor T-cell factor/lymphoid enhancer factor (TCF/LEF) and on -catenin, indicating that the Wnt signaling pathway is involved in repression (33, 34).”
BackgroundSelf-citationShen, C., Chen, M.-T., Zhang, X.-H., Yin, X.-L., Ning, H.-M., Su, R., Lin, H.-S., Song, L., Wang, F., Ma, Y.-N., et al. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006259 · Cited by 62
“1 has been shown to play a decisive role in lympho-myeloid development and its stage-specific expression is critical to prevent leukemic transformation [39,40].”
BackgroundRetractedRothenberg, E. V., Ungerbäck, J., & Champhekar, A. (2016) · Advances in Immunology · doi:10.1016/bs.ai.2015.09.002 · Cited by 61
Tung, J. W., & Herzenberg, L. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.02.012 · Cited by 65
Pang, S. H. M., de Graaf, C. A., Hilton, D. J., Huntington, N. D., Carotta, S., Wu, L., & Nutt, S. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01264 · Cited by 60
“1 function in adult BM lymphopoiesis, recent analysis of mice homozygous for a hypomorphic allele of Spi1 [UREΔ/Δ (20)] demonstrated a concentration dependent function for PU.”
BackgroundHikami, K., Kawasaki, A., Ito, I., Koga, M., Ito, S., Hayashi, T., Matsumoto, I., Tsutsumi, A., Kusaoi, M., Takasaki, Y., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30188 · Cited by 58
“08) Control 151 (34) 212 (47) 87 (19) 0.”
MethodTranscriptional Control of Macrophage Identity, Self-Renewal, and Function
Molawi, K., & Sieweke, M. H. (2013) · Advances in immunology · doi:10.1016/b978-0-12-417028-5.00010-7 · Cited by 62
“Expression levels of PU.1 are controlled not only through cis-regulatory elements of the gene, which are critical for PU.1-induced lineage decisions (Okuno et al., 2005; Rosenbauer et al., 2006), but also on the message level via miRNA-155 (Xiao & Rajewsky, 2009).”
BackgroundGuzmán, M. L., Yang, N., Sharma, K. K., Balys, M. M., Corbett, C. A., Jordan, C. T., Becker, M. W., Steidl, U. G., Abdel-Wahab, O. I., Levine, R. L., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0963 · Cited by 56
“1 hypomorphic (URE)mice for which LSC and pre-LSC populations have already been well characterized (36, 37).”
BackgroundSelf-citationYing, J., Gao, Z., Li, H., Srivastava, G., Murray, P. G., Goh, H. K., Lim, C. Y., Wang, Y., Marafioti, T., Mason, D. Y., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06512.x · Cited by 54
Wontakal, S. N., Guo, X., Will, B., Shi, M., Raha, D., Mahajan, M. C., Weissman, S., Snyder, M., Steidl, U., Zheng, D., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001392 · Cited by 53
“1 low erythroid progenitors relative to wild-type progenitors (Figure 3C), similar to reports in other cell types [30,32,33].”
BackgroundResultSelf-citationAnalysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models
DeKoter, R. P., Kamath, M. B., & Houston, I. B. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.06.004 · Cited by 63
Zarnegar, M. A., Chen, J., & Rothenberg, E. V. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00354-10 · Cited by 52
“1 expression within hematopoietic cells nor fully blocked T-cell silencing (28, 29).”
BackgroundTatetsu, H., Ueno, S., Hata, H., Yamada, Y., Takeya, M., Mitsuya, H., Tenen, D. G., & Okuno, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4265 · Cited by 51
“1 to 20% of the wild-type (WT) level, and all the knockout mice developed acute myeloid leukemia, T-cell lymphomas, and/or chronic lymphocytic leukemia–like disease (9, 10).”
BackgroundSelf-citationHouston, I. B., Kamath, M. B., Schweitzer, B. L., Chlon, T. M., & DeKoter, R. P. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.04.005 · Cited by 49
Cross talk between Wnt/β-catenin and Irf8 in leukemia progression and drug resistance
Scheller, M., Schönheit, J., Zimmermann, K., Leser, U., Rosenbauer, F., & Leutz, A. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130706 · Cited by 48
Self-citationPU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells
Yuki, H., Ueno, S., Tatetsu, H., Niiro, H., Iino, T., Endo, S., Kawano, Y., Komohara, Y., Takeya, M., Hata, H., et al. (2012) · Blood · doi:10.1182/blood-2012-05-431429 · Cited by 56
Self-citationCharacteristics of Antisense Transcript Promoters and the Regulation of Their Activity
Lin, S., Zhang, L., Luo, W., & Zhang, X. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms17010009 · Cited by 49
“1 plays a key role in the fate of certain cells, and a slight decrease in its expression can lead to leukemia and lymphoma [79,80].”
BackgroundRUNX1: A MicroRNA Hub in Normal and Malignant Hematopoiesis
Rossetti, S., & Sacchi, N. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011566 · Cited by 51
Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy
Dahl, M., Kristensen, L. S., & Grønbæk, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092475 · Cited by 50
“1 expression levels are necessary for the transition of B1 to B2 cells, and since failure to perform this lineage commitment has been linked to malignant transformation [53], the antisense PU.”
BackgroundDendritic cell development requires histone deacetylase activity
Chauvistré, H., Küstermann, C., Rehage, N., Klisch, T., Mitzka, S., Felker, P., Rose‐John, S., Zenke, M., & Seré, K. (2014) · European Journal of Immunology · doi:10.1002/eji.201344150 · Cited by 50
Zhang, C., Shao, Y., Zhang, W., Wu, Q., Yang, H. S., Zhong, Q., Zhang, J., Guan, M., Yu, B., & Wan, J. (2009) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2009.08.016 · Cited by 45
Ye, Y., Kang, X., Bailey, J., Li, C., & Hong, T. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006855 · Cited by 48
Regulating the Regulators: The Role of Histone Deacetylase 1 (HDAC1) in Erythropoiesis
Kim, M. Y., Yan, B., Huang, S., & Qiu, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228460 · Cited by 52
Competition and collaboration: GATA-3, PU.1, and Notch signaling in early T-cell fate determination
Rothenberg, E. V., & Scripture-Adams, D. D. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.07.006 · Cited by 43
“1 expression [75](see above), then their own downregulation as the cells become fully converted mast-cell precursors may help to explain why PU.”
BackgroundKamath, M. B., Houston, I. B., Janovski, A. J., Zhu, X., Gowrisankar, S., Jegga, A. G., & DeKoter, R. P. (2008) · Leukemia · doi:10.1038/leu.2008.67 · Cited by 41
Regulatory gene network circuits underlying T cell development from multipotent progenitors
Kueh, H. Y., & Rothenberg, E. V. (2012) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.162 · Cited by 41
“The data sources used for this T-cell network reconstruction are listed in Supplementary Table 1, together with the approaches used to evaluate regulatory network linkages in each study [28, 35, 42, 44, 52-96].”
Bruns, I., Steidl, U. G., Fischer, J., Czibere, A. G., Kobbe, G., Raschke, S., Singh, R., Fenk, R. R., Rosskopf, M., Pechtel, S., et al. (2008) · Haematologica · doi:10.3324/haematol.12081 · Cited by 41
Self-citationJNK‐dependent gene regulatory circuitry governs mesenchymal fate
Sahu, S. K., Garding, A., Tiwari, N., Thakurela, S., Toedling, J., Gebhard, S., Ortega, F., Schmarowski, N., Berninger, B., Nitsch, R., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490693 · Cited by 40
“…following inhibition of JNK signaling, all are known to inhibit EMT and tumor progression as well as promote epithelial properties (Spath & Weiss, 1998; Walter et al , 2005; Rosenbauer et al , 2006; Valcourt et al , 2007; Ohshima et al , 2009; Tanaka-Okamoto et al , 2009; Santangelo et al , 2011).”
Using random walks to identify cancer-associated modules in expression data
Petrochilos, D., Shojaie, A., Gennari, J. H., & Abernethy, N. F. (2013) · BioData Mining · doi:10.1186/1756-0381-6-17 · Cited by 47
PU.1 is regulated by NF-κB through a novel binding site in a 17 kb upstream enhancer element
Bonadies, N., Neururer, C., Steege, A., Vallabhapurapu, S., Pabst, T., & Mueller, B. U. (2009) · Oncogene · doi:10.1038/onc.2009.371 · Cited by 47
“1 expression in combination with b-catenin (Rosenbauer et al., 2006).”
Ivascu, C., Wasserkort, R., Lesche, R., Dong, J., Stein, H., Thiel, A., & Eckhardt, F. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.02.006 · Cited by 43
Yun, H., Narayan, N., Vohra, S., Giotopoulos, G., Mupo, A., Madrigal, P., Sasca, D., Lara‐Astiaso, D., Horton, S. J., Singh, S. A., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00925-9 · Cited by 40
“Mice with a genetically engineered decrease in PU.1 expression develop AML 35,36,54,55 .”
STAT5-mediated self-renewal of normal hematopoietic and leukemic stem cells
Schepers, H., Wierenga, A. T. J., Vellenga, E., & Schuringa, J. J. (2012) · JAK-STAT · doi:10.4161/jkst.19316 · Cited by 43
T-ALL leukemia stem cell 'stemness' is epigenetically controlled by the master regulator SPI1
Zhu, H., Zhang, L., Wu, Y., Dong, B., Guo, W., Wang, M., Yang, L., Fan, X., Tang, Y., Liu, N., et al. (2018) · eLife · doi:10.7554/elife.38314 · Cited by 41
“b-Catenin is an important transcription factor regulating Spi1 expression in the T cell lineage (Rosenbauer et al., 2006).”
BackgroundSingle-cell insights into the hematopoietic generation of T-lymphocyte precursors in mouse and human
Rothenberg, E. V. (2021) · Experimental Hematology · doi:10.1016/j.exphem.2020.12.005 · Cited by 40
“The phase 1 genes are usually considered part of non-T-cell programs, and many are associated with Tlineage oncogenesis if they are expressed after commitment (reviewed in [25,52,53]) [54,55].”
BackgroundTenney, A. P., Gioia, S. A. D., Webb, B. D., Chan, W. M., de Boer, E., Garnai, S. J., Barry, B. J., Ray, T., Kosicki, M., Robson, C. D., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01424-9 · Cited by 34
Metadata
- Authors
- Rosenbauer, F., Owens, B. M., Yu, L., Tumang, J. R., Steidl, U., Kutok, J. L., Clayton, L. K., Wagner, K., Scheller, M., Iwasaki, H., Liu, C., Hackanson, B., Akashi, K., Leutz, A., Rothstein, T. L., Plass, C., & Tenen, D. G.
- Affiliations
- Harvard University (US)
- The Ohio State University (US)
- Boston University (US)
- Brigham and Women's Hospital (US)
- Leibniz University Hannover (DE)
- Max Delbrück Center (DE)
- Corresponding author
- Rosenbauer, Frank
- Tenen, Daniel G
- ORCID
- Venue
- Nature Genetics
- Published
- 2005-11-27
- Volume
- 38
- Issue
- 1
- Pages
- 27-37
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2100126911
- Cited by
- 237
- References
- 51
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 15 · 2023: 11 · 2022: 5 · 2021: 8 · 2020: 9 · 2019: 11 · 2018: 10 · 2017: 8 · 2016: 15 · 2015: 9 · 2014: 7 · 2013: 19 · 2012: 13
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- PU.1, upstream regulatory sequences, enhancers, transcriptional repression, T cell development, B cell development, acute myeloid leukemia, TCF transcription factors, Wnt signaling, DNA methylation, epigenetic silencing, tumor suppressor, cis-regulatory elements
- MeSH terms
- Proto-Oncogene Protein Spi-1, Animals, B-Lymphocytes, Cell Transformation, Neoplastic, Gene Expression Regulation, Lymphocytes, Mice, Transgenic, Promoter Regions, Genetic, Proto-Oncogene Proteins, Regulatory Sequences, Nucleic Acid, Stem Cells, Thymus Gland, Signal Transduction, Trans-Activators, Lymphoma, T-Cell, Mice, SCID, Thy-1 Antigens, DNA Methylation, Wnt Proteins, beta Catenin, Mice, TCF Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.